Insider Cluster (3 insiders) ·Filed Sep 15, 2026

ORKA

Oruka Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed16d 16h ago
Insider cluster: 2 insiders, $288K total
Actionable Insight • Neutral

Three Oruka insiders (CEO, COO, SVP Finance) sold a combined $375,574.92 in open-market sales on 2026-09-15. The cluster is small relative to the company's $6.4B market cap (~0.006%), making it immaterial from a dollar-value perspective. All three sales occurred on the same date at the same price, consistent with a shared blackout-window opening or vesting event rather than a coordinated bearish signal. Per the asymmetric calibration, cluster sells are not amplified, and the dollar value is trivial relative to company size.

DirectionNeutral
Confidencemedium
Horizondays
Latest settled — T+5d
ORKA ▼ -3.87% at T+5d
NEUTRAL call ✗ call lost -3.87% · α vs SPY -6.44% · entry $93.55 → $89.93
Next anchor: T+20d in 11d
Latest observation: T+10 -19.52% FF3 residual α
Entry anchored
Sep 15, 2026
via day open
T+1d
+4.47%
call +4.47% · α +3.33%
$97.73
settled 16d ago
T+5d
-3.87%
call -3.87% · α -6.44%
$89.93
settled 10d ago
T+20d
—
call — · α —
—
in 11d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

Three Oruka insiders (CEO, COO, SVP Finance) sold a combined $375,574.92 in open-market sales on 2026-09-15. The cluster is small relative to the company's $6.4B market cap (~0.006%), making it immaterial from a dollar-value perspective. All three sales occurred on the same date at the same price, consistent with a shared blackout-window opening or vesting event rather than a coordinated bearish signal. Per the asymmetric calibration, cluster sells are not amplified, and the dollar value is trivial relative to company size.

Key Financial Metrics

Direction
selling
Total Value
$375.6K
Insiders
3

Financial Impact

Not specified

Risk Factors

  • Insider sales cluster on a single date may indicate a shared liquidity event (vesting, blackout window) rather than fundamental deterioration.
  • The cluster is immaterial relative to market cap (<0.1%), limiting its predictive value.
  • Pharmaceutical sector volatility could amplify any negative reaction to perceived insider pessimism.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ORKA-1789514294477
26 reports for ORKA
Performance horizon
100% Hit rate 11 of 11 directional calls best @ T+60▲ +80.05%Jun 1, 2026
Filters
Rows
Reports for ORKA — sortable, filterable
TypeNow
Sep 15, 2026
16d ago
Insider Cluster
NEUTRAL ★ 3/10
$93.55 $89.93▼ −3.87%▼ −6.44%$84.38 (−9.80%)
Sep 1, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$91.63 $91.65▼ −0.02%▼ −0.98%$84.38 (+7.91%)
Aug 28, 2026
5w ago
EFFECT
BEARISH ★ 6/10
$91.15 $92.51▼ −1.50%▼ −1.39%$84.38 (+7.42%)
Aug 17, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$113.08 $101.82▼ −9.96%▼ −9.76%$84.38 (−25.38%)
Aug 10, 2026
7w ago
Press Release
BULLISH ★ 7/10
$105.14 $112.66▲ +7.15%▲ +7.20%$84.38 (−19.75%)
Aug 10, 2026
7w ago
8-K
BULLISH ★ 6/10
$105.14 $112.66▲ +7.15%▲ +7.20%$84.38 (−19.75%)
Aug 9, 2026
7w ago
Institutional Cluster
BULLISH ★ 7/10
$105.14 $112.66▲ +7.15%▲ +7.20%$84.38 (−19.75%)
Jul 15, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$83.04 $91.95▲ +10.73%▲ +12.40%$84.38 (+1.61%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 5/10
$85.21 $88.27▲ +3.59%▲ +2.66%$84.38 (−0.97%)
Jun 22, 2026
14w ago
Insider Cluster
NEUTRAL ★ 3/10
$83.40 $92.49▲ +10.90%▲ +9.89%$84.38 (+1.18%)
Showing 10 of 26

US Market Status

Market Open — Closes in 3h 54m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 15, 2026